Backed by government and industry partners, Micro-X is pushing its cold-cathode X-ray tech toward commercial readiness.

Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

Rare earths and mineral sands hopeful Ark Mines wants to ride a wave of government support to production as soon as 2027.

Salary sacrificing promises instant tax savings and a bigger nest egg, but it seems to have lost its lustre. Here’s why.